Shashank Srowthy to succeed Lokesh Chandak as CFO of P&G Health
Mumbai: Procter & Gamble Health Limited has appointed Shashank Srowthy as Chief Financial Officer (CFO) of the Company and Additional (Executive) Director effective October 1, 2025. His appointment is subject to the allotment of a Director Identification Number by the Ministry of Corporate Affairs.
Srowthy succeeds Lokesh Chandak, who will step down as Director & CFO effective close of business hours of September 30, 2025, as he will be moving onto his new assignment in P&G as Senior Director – Finance & Accounting, Feminine Care- Asia Pacific Enterprise Markets, Middle East and Africa.
Procter & Gamble Health Limited was set up in India as one of Merck’s Asian subsidiaries in 1967. It was also the first Merck Group Company to go public in the year 1981. Till 2018, the Company was operating in all businesses included in the pharmaceuticals and chemicals businesses in the country.
Read also: P&G Health partners with Indian Medical Association for launch of VitaM.I.N.D.S conclave
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.